Clinical Trials Logo
  1. Home
  2. Inflammatory Bowel Disease
  3. NCT02790281
  4. Details
NCT02790281 Clinical Trial

A Study to Investigate Interleukin-6 (IL-6) and IL-6/Soluble IL-6 Receptor (sIL-6R) Complex Levels in Subjects With Active Inflammatory Bowel Disease

Inflammatory Bowel Disease Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT02790281
Other study ID # 07031-01
Secondary ID
Status Completed
Phase N/A
First received May 18, 2016
Last updated June 2, 2016
Start date December 2014
Est. completion date August 2015

Study information
Verified date May 2016
Source Ferring Pharmaceuticals
Contact n/a
Is FDA regulated No
Health authority Denmark: Ethics CommitteeSweden: Regional Ethical Review Board
Study type Interventional

Clinical Trial Summary

The purpose of this study is to measure IL-6 and IL-6/sIL-6R complex levels in subjects with active moderate to severe ulcerative colitis or Crohn's disease.

Recruitment information / eligibility
Status Completed
Enrollment 0
Est. completion date August 2015
Est. primary completion date August 2015
Accepts healthy volunteers
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Subjects diagnosed with active moderate to severe ulcerative colitis (*partial Mayo = 5) or Crohn's disease (Harvey & Bradshaw = 8) *partial Mayo: 9-point scale that excludes the endoscopic components of the Mayo score

Exclusion Criteria:

- Presence of another inflammatory disease, except for mild cutaneous psoriasis

- Concomitant gastrointestinal infection or otherwise serious infection including Crohn's disease infectious complication

- Treatment with Infliximab, Adalimumab, Certolizumab Pegol or other immune-modulating biologics within 8 weeks prior to the visit

- Having a known or suspected gastrointestinal or otherwise serious infection within 8 weeks prior to the visit

- Concomitant diagnosed or suspected malignant disease

Study Design

N/A

Related Conditions & MeSH terms

Intervention

Procedure:
• Blood sampling
Blood sample collected at a single visit

Locations
Country Name City State
Denmark Herlev hospital (there may be other sites in this country) Herlev
Sweden Skane University Hospital (there may be other sites in this country) Lund

Sponsors (1)
Lead Sponsor Collaborator
Ferring Pharmaceuticals

Countries where clinical trial is conducted

Denmark,  Sweden, 

Outcome
Type Measure Description Time frame Safety issue
Primary Exploratory: Levels of IL-6/sIL-6R complex At visit 1
Primary Exploratory: Levels of IL-6 At visit 1
Primary Exploratory: Levels of C-reactive protein (CRP) At visit 1
See also
  Status Clinical Trial Phase
Withdrawn NCT03278912 - Natural History of Intestinal Inflammation in People With Primary Immune Dysregulations
Terminated NCT00061282 - Clotrimazole Enemas for Pouchitis in Children and Adults Phase 1/Phase 2
Recruiting NCT05579392 - A Randomized Crossover Trial of Bright Light Therapy in Crohn's Disease on Intestinal Barrier Homeostasis N/A
Completed NCT03264690 - Study to Observe the Change in Microbiome in Human Derived Sample and the Relation With Clinical Response Before and After the Anti-TNF Treatment in IBD Patients
Recruiting NCT02861053 - Inflammatory Bowel Disease : Could a Regular Physical Activity Reduce Patients Fatigue ? N/A
Recruiting NCT02275676 - Resting Energy Expenditure and Nutritional Status in IBD N/A
Completed NCT02503696 - Sample Collection Study to Evaluate DNA Markers in Subjects With Inflammatory Bowel Disease (IBD) N/A
Completed NCT02197780 - Head-to-head Comparison of Two Fecal Biomarkers to Screen Children for IBD N/A
Completed NCT02161640 - Vascular Dysfunction in Paediatric IBD N/A
Completed NCT01860651 - Web-based Monitoring in Children and Adolescents With Inflammatory Bowel Disease N/A
Completed NCT01933867 - Water-aided Colonoscopy in Inflammatory Bowel Disease Patients N/A
Completed NCT01852760 - Assessment of Disease Activity in Ulcerative Colitis by Endoscopic Ultrasound N/A
Completed NCT01692743 - Telemedicine in Patients With Inflammatory Bowel Disease (TELE-IBD) Phase 3
Completed NCT01666535 - Infliximab IBD Influenza Vaccine Study N/A
Completed NCT01676324 - FOCUS: The Future of Fecal Calprotectin Utility Study for the Diagnosis and Management of Inflammatory Bowel Disease (IBD) N/A
Completed NCT01688557 - Trial on Innovative Technologies in Colonoscopy N/A
Completed NCT01981616 - Immune Response to Systemic and Mucosal Antigenic Challenge in the Presence of Vedolizumab Phase 1
Completed NCT01557387 - Real-time Diagnosis of Pseudopolyps During Colonoscopy
Completed NCT01476995 - Prognostic Indicators as Provided by the EPIC ClearView N/A
Completed NCT01221818 - A Randomized, Double-Blind, Placebo-Controlled, Ascending Single Dose Study of E6007 in Healthy Subjects Phase 1